Transcription Factor-Directed Therapies Summit

Temas de la conferencia
Following significant progress in obtaining structural insights from transcription factor-DNA (TF-DNA) complexes using techniques like cryo-electron microscopy, Biotech is continuing to pour investment into developing therapeutic interventions to address increased expression of specific transcription factor associated oncogenes and oncogene amplification in cancer.

Organizador profesional (PCO)
Hanson Wade

Observaciones
Speakers: Alex Federation, Co-Founder and Chief Executive Officer, Talus Bio, Alon Goren, Assistant Professor, University of California San Diego, Ben Amidon, Senior Director, Ikena Oncology and more.

https://go.evvnt.com/955983-2?pid=4832

Ms. Hollie Bulfin